Skip to main content
Fig. 3 | Orphanet Journal of Rare Diseases

Fig. 3

From: Epidemiological and advanced therapeutic approaches to treatment of uveitis in pediatric rheumatic diseases: a systematic review and meta-analysis

Fig. 3

The efficacy of Infliximab to treat JIA-related uveitis. To determine the efficacy of Infliximab, 476 patients were tested for the medications leading to a pooled response rate of 64.7% (95%CI: 59.8 to 69.3%). In this regard, the statistical heterogeneity was also significant with an I2of 73.066% (P < 0.001). There was no significant publication bias (P = 234)

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172